A Study to Investigate the Efficacy and Safety of Eribulin in Korean Breast Cancer Participants

Condition:   Locally Advanced or Metastatic Breast Cancer Intervention:   Drug: Eribulin mesylate Sponsor:   Eisai Korea Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials